Keyphrases
Anticancer Drugs
100%
Organic Anion Transporter
100%
MRP3
100%
Multidrug Resistance Protein 1 (MDR1)
36%
Multidrug Resistance-associated Protein 2 (MRP2)
27%
Overexpressing
18%
Multidrug Resistance Protein
18%
Glutathione
18%
Madin-Darby Canine Kidney (MDCK) Cells
18%
Cancer Cells
9%
Protein-coding Genes
9%
Etoposide
9%
Methotrexate
9%
Gene Family
9%
Drug Resistance
9%
Drug Exposure
9%
Potential Contribution
9%
Monoclonal Antibody
9%
Complementary DNA (cDNA)
9%
Epipodophyllotoxin
9%
Teniposide
9%
Multidrug Transporter
9%
Multispecific
9%
Exposure Experiment
9%
Basolateral Membrane
9%
Ovarian Carcinoma Cells
9%
MRP5
9%
MRP6
9%
High-level Resistance
9%
Mrp4
9%
Organic Anions
9%
Dinitrophenyl
9%
Low-level Resistance
9%
Hepatic Physiology
9%
Intracellular Glutathione
9%
Medicine and Dentistry
Anticarcinogen
100%
Multidrug Resistance Associated Protein 3
100%
Organic Anion Transporter
100%
Multidrug Resistance Associated Protein 2
45%
Multidrug Resistance Associated Protein 1
36%
ABC Transporter Subfamily B
27%
Glutathione
27%
Cancer Cell
9%
Cell Line
9%
Etoposide
9%
Methotrexate
9%
Monoclonal Antibody
9%
Drug Resistance
9%
Drug Exposure
9%
Carcinoma Cell
9%
Complementary DNA
9%
Krukenberg Tumor
9%
Teniposide
9%
Epipodophyllotoxin
9%
Multigene Family
9%
Basolateral Membrane
9%
Multidrug Resistance Associated Protein 4
9%
Multidrug Resistance Protein 5
9%
2,4 Dinitrophenol
9%
Pharmacology, Toxicology and Pharmaceutical Science
Anticarcinogen
100%
Multidrug Resistance Associated Protein 3
100%
Organic Anion Transporter
100%
Multidrug Resistance-Associated Protein 2
45%
Multidrug Resistance Associated Protein 1
36%
P-Glycoprotein
27%
Glutathione
27%
Malignant Neoplasm
9%
Etoposide
9%
Methotrexate
9%
Drug Resistance
9%
Monoclonal Antibody
9%
Teniposide
9%
Epipodophyllotoxin
9%
Ovary Carcinoma
9%
Complementary DNA
9%
Multidrug Resistance Protein 5
9%
Multidrug Resistance Associated Protein 4
9%
2,4-Dinitrophenol
9%
Immunology and Microbiology
P-Glycoprotein
100%
Organic Anion Transporter
100%
Cancer Cell
33%
Methotrexate
33%
Drug Resistance
33%
Cell Line
33%
Drug Exposure
33%
Monoclonal Antibody
33%
Carcinoma Cell
33%
Multigene Family
33%
Basolateral Membrane
33%